In the wake of yesterday's historic court ruling against Myriad Genetics, Kartemquin's In the Family is featured in a special segment on today's All Things Considered on NPR (available to live stream here from 7pm ET). The film's director, Joanna Rudnick, has also been interviewed by the Chicago Tribune about the case, which she cited as a "landmark victory for all women and families with BRCA mutations, as well as a precedent-setting decision for the case against patenting forms of nature."
The ruling by the Southern District of New York was in favor of the plaintiffs, led by the ACLU, who challenged Myriad Genetics right to hold patents on the BRCA1 and BRCA2 genes, which are associated with breast and ovarian cancer. NPR states that "the ruling has far-reaching implications for the patenting of human genes," and the case has created a media storm.
Rudnick, who has a mutation in the BRCA1 gene, documented her own investigation into the ethics of Myriad's patents in In the Family, and has presented special screenings of the film in conjunction with the ACLU to raise awareness of the case. Click here to read a Huffington Post blog by Rudnick about the case, and watch a clip of In the Family in which she interviews Founder and Chief Scientific Officer of Myriad, Dr. Mark Skolnick.
With a noted tradition of nurturing emerging talent and acting as a leading voice for independent media, Kartemquin is building on more than 50 years of history as Chicago’s documentary powerhouse.
Kartemquin is a 501(c)3 not-for-profit organization. Guidestar
© 2017 Kartemquin Educational Films
Sign up for the Kartemquin newsletter
Get film updates and special deals